Publications by authors named "Michael Boyer"

100Publications

Endothelial cell-derived extracellular vesicles alter vascular smooth muscle cell phenotype through high-mobility group box proteins.

J Extracell Vesicles 2020 Jun 18;9(1):1781427. Epub 2020 Jun 18.

Cardiovascular Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/20013078.2020.1781427DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480479PMC
June 2020

Case of post-progression prolongation of survival after cessation of pembrolizumab in advanced non-small-cell lung cancer.

Intern Med J 2020 Jun;50(6):771-773

Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.14852DOI Listing
June 2020

Mitochondrial Fission Mediates Endothelial Inflammation.

Hypertension 2020 Jul 11;76(1):267-276. Epub 2020 May 11.

From the Cardiovascular Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA (S.J.F., K.J.P., H.A.C., M.J.B., K.M.E., A.J.P., K.J.E., R.K., M.M., V.R., R.S., S.E.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.14686DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289685PMC
July 2020

COVID-19: the use of immunotherapy in metastatic lung cancer.

Immunotherapy 2020 06 30;12(8):545-548. Epub 2020 Apr 30.

Chris O'Brien Lifehouse, Department of Medical Oncology, 119-143 Missenden Road, Camperdown NSW 2050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2020-0096DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202359PMC
June 2020

Clinical Trials Eligibility of Patients With Malignant Pleural Mesothelioma: Use of Novel Therapies and Outcomes.

Clin Lung Cancer 2020 Jul 7;21(4):378-383.e1. Epub 2020 Mar 7.

Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Asbestos Diseases Research Institute, Hospital Road, Concord, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2020.01.007DOI Listing
July 2020

Transduction Efficiency of Adenovirus Vectors in Endothelial Cells and Vascular Smooth Muscle Cells.

J Cardiovasc Pharmacol 2020 Jun;75(6):603-607

Cardiovascular Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FJC.0000000000000821DOI Listing
June 2020

Using CD19 chimeric antigen receptor-T cell therapy in a 4-month-old patient with infantile acute lymphoblastic leukemia.

Pediatr Blood Cancer 2020 04 11;67(4):e28155. Epub 2020 Jan 11.

Division of Pediatric Hematology/Oncology, University of Utah School of Medicine, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.28155DOI Listing
April 2020

A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma.

Cell Transplant 2019 Dec 16;28(12):1624-1631. Epub 2019 Oct 16.

Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0963689719880541DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923548PMC
December 2019

Aerobic exercise during chemotherapy infusion for cancer treatment: a novel randomised crossover safety and feasibility trial.

Support Care Cancer 2020 Feb 21;28(2):625-632. Epub 2019 May 21.

Faculty of Health Sciences, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-04871-5DOI Listing
February 2020

Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells.

CPT Pharmacometrics Syst Pharmacol 2019 05 7;8(5):285-295. Epub 2019 Mar 7.

Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/psp4.12388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539725PMC
May 2019

Processed human amniotic fluid retains its antibacterial activity.

J Transl Med 2019 03 1;17(1):68. Epub 2019 Mar 1.

Department Hematology & Hematologic Malignancies, University of Utah, Salt Lake City, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-019-1812-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397468PMC
March 2019

A cytoskeletal anchor connects ischemic mitochondrial fission to myocardial senescence.

Sci Signal 2018 11 13;11(556). Epub 2018 Nov 13.

Cardiovascular Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scisignal.aav3267DOI Listing
November 2018

Mice deficient in the mitochondrial branched-chain aminotransferase (BCATm) respond with delayed tumour growth to a challenge with EL-4 lymphoma.

Br J Cancer 2018 10 15;119(8):1009-1017. Epub 2018 Oct 15.

Department of Human Nutrition, Foods, and Exercise, Virginia Tech, Integrated Life Sciences Building 0913, 1981 Kraft Drive Blacksburg, Blacksburg, VA, 24060, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0283-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203766PMC
October 2018

Novel role for cardiac myocyte-derived β-2 microglobulin in mediating cardiac fibrosis.

Clin Sci (Lond) 2018 10 5;132(19):2117-2120. Epub 2018 Oct 5.

Cardiovascular Research Center, Lewis Katz School of Medicine, Temple University, 3500 N. Broad Street, Philadelphia, PA 19140, U.S.A.

View Article

Download full-text PDF

Source
http://clinsci.org/lookup/doi/10.1042/CS20180681
Publisher Site
http://dx.doi.org/10.1042/CS20180681DOI Listing
October 2018

Chimeric antigen receptor T-cell therapy hits the market.

Authors:
Michael W Boyer

Immunotherapy 2018 08;10(11):911-912

Associate Professor of Pediatrics & Internal Medicine, University of Utah, Division of Pediatric Hematology/Oncology/BMT, 100 N Mario Capecchi Dr, Salt Lake City, UT 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2018-0075DOI Listing
August 2018

Targeted Molecular Treatments in Non-Small Cell Lung Cancer: A Clinical Guide for Oncologists.

J Clin Med 2018 Jul 31;7(8). Epub 2018 Jul 31.

Chris O'Brien Lifehouse, 119-143 Missenden Road Camperdown, Camperdown, NSW 2050, Australia.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2077-0383/7/8/192
Publisher Site
http://dx.doi.org/10.3390/jcm7080192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111731PMC
July 2018

An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer.

J Clin Med 2018 Jun 15;7(6). Epub 2018 Jun 15.

Sydney Medical School, The University of Sydney, Sydney 2006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm7060153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025105PMC
June 2018

Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms.

J Clin Med 2018 Jun 14;7(6). Epub 2018 Jun 14.

Sydney Medical School, The University of Sydney, Camperdown, NSW 2006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm7060151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024943PMC
June 2018

Understanding Immune Tolerance of Cancer: Re-Purposing Insights from Fetal Allografts and Microbes.

Bioessays 2018 08 4;40(8):e1800050. Epub 2018 Jun 4.

The Garvan Institute of Medical Research, Darlinghurst, 2010, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bies.201800050DOI Listing
August 2018

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.

N Engl J Med 2018 May 16;378(22):2078-2092. Epub 2018 Apr 16.

From NYU Perlmutter Cancer Center, New York (L.G.); Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria (D.R.-A.), Hospital Universitario Central de Asturias, Oviedo (E.E.), Vall d'Hebron University, Vall d'Hebron Institute of Oncology, Barcelona (E.F.), and Fundación Jiménez Díaz (M.D.) and Hospital Universitario Quirón Madrid (B.R.-V.), Madrid - all in Spain; Karmanos Cancer Institute, Detroit (S.G.); Integrated Health and Social Services Centres, Montérégie Centre, Greenfield Park, QC (F.D.A.), and Sunnybrook Health Sciences Centre, Toronto (S.Y.-S.C.) - both in Canada; Southern Medical Day Care Centre, Wollongong, NSW (P.C.), Epworth Healthcare, Richmond, VIC (R.R.J.), Westmead Hospital and University of Sydney, Sydney (R.H.), and Chris O'Brien Lifehouse, Camperdown, NSW (M.B.) - all in Australia; Otto Wagner Hospital, Vienna (M.J.H.); Sanford Health, Sioux Falls, SD (S.F.P.); Thoraxklinik, Heidelberg (H.G.B.), and LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf (M.R.) - both in Germany; Davidoff Cancer Center, Tel Aviv University, Petah Tikva, Israel (N.P.); Ospedale Policlinico San Martino, Genoa (F.G.), University of Turin, Azienda Ospedaliero-Universitaria San Luigi, Orbassano (S.N.), and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (M.C.G.) - all in Italy; David Geffen School of Medicine at UCLA, Los Angeles (E.B.G.); Kansai Medical University Hospital, Osaka, Japan (T.K.); Moffitt Cancer Center, Tampa, FL (J.E.G.); and Merck, Kenilworth, NJ (J.V., Z.W., J.Y., H.R., M.C.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1801005DOI Listing
May 2018

Dose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trials.

Asia Pac J Clin Oncol 2018 Jun 2;14(3):125-133. Epub 2018 Mar 2.

Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12864DOI Listing
June 2018

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

N Engl J Med 2018 02;378(5):439-448

From the Departments of Pediatrics (S.L.M., S.A.G.) and Pathology and Laboratory Medicine (C.H.J., B.L.L.), Perelman School of Medicine, and Abramson Cancer Center (C.H.J., B.L.L.), University of Pennsylvania, and the Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia (S.L.M., S.A.G.) - all in Philadelphia; the Department of Pediatrics and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, and the Pauline Allen Gill Center for Cancer and Blood Disorders, Children's Health, Dallas (T.W.L.); the Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo (J.B.); the Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Deu Barcelona, Barcelona (S.R.); the Department of Pediatrics and Internal Medicine, University of Utah, Salt Lake City (M.B.); the Department of Pediatrics, Faculty of Medicine, University of Montreal, and the Hematology Oncology Division and Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montreal (H.B.), and the Division of Haematology/Oncology/Bone Marrow Transplantation, Hospital for Sick Children, Toronto (J.K.) - all in Canada; the Division of Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, University Hospital Frankfurt, Frankfurt, Germany (P.B.); the Division of Pediatric Blood and Marrow Transplant, University of Minnesota, Minneapolis (M.R.V., H.E.S.); Children's Mercy Hospital and Clinics, Kansas City, MO (G.D.M.); Aflac Cancer and Blood Disorders Center, Emory University, Atlanta (M.Q.); the Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, and the Cancer Research Institute Ghent (CRIG), Ghent, Belgium (B.D.M.); the Department of Pediatrics, Graduate School of Medicine Kyoto University, Kyoto, Japan (H.H.); the Department of Pediatrics, Stanford University School of Medicine, Stanford (K. Schlis, K.L.D.), and the Division of Hematology, Oncology, Blood and Marrow Transplant, Children's Hospital Los Angeles, USC Keck School of Medicine, Los Angeles (M.A.P.) - all in California; the Division of Pediatric Blood and Marrow Transplant, Duke University Medical Center, Durham, NC (P.L.M.); Oregon Health and Science University, Portland (E.R.N.); C.S. Mott Children's Hospital, Ann Arbor, MI (G.A.Y.); the Stem Cell Transplantation Unit, St. Anna Children's Hospital, Vienna (C.P.); University Hospital Robert Debré and University Paris Diderot (A. Baruchel), and Saint-Louis Hospital and University Paris Diderot (N.B.), Paris; the Royal Children's Hospital, Melbourne, VIC, Australia (F.M.); Clinica Pediatrica Universita degli Studi di Milano Bicocca, Monza, Italy (A. Balduzzi); and Novartis Pharmaceuticals (P.W., T.T., M.L., Y.Z., K. Sen, D.L.) and Novartis Institutes for Biomedical Research (K.T.M.) - both in East Hanover, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709866DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996391PMC
February 2018

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

J Clin Oncol 2017 Dec 17;35(36):4003-4011. Epub 2017 Oct 17.

Robert J. Soiffer, Haesook T. Kim, Vincent T. Ho, Edwin P. Alyea, and Jerome Ritz, Dana-Farber Cancer Institute; James D. Levine, Beth Israel Deaconess Medical Center and Harvard Medical School; Yi-Bin Chen, Massachusetts General Hospital, Boston; Frank Glavin, Neovii Biotech, Lexington, MA; Joseph McGuirk, University of Kansas Medical Center, Kansas City, KS; Mitchell E. Horwitz, Duke University Medical Center, Durham; Thomas C. Shea, University of North Carolina School of Medicine, Chapel Hill, NC; Laura Johnston, Stanford University, Stanford, CA; Mrinal M. Patnaik, Mayo Clinic, Rochester, MN; Witold Rybka, Penn State College of Medicine, Hershey; David L. Porter, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Andrew Artz, University of Chicago, Chicago; Patrick J. Stiff, Loyola University Medical Center, Maywood, IL; Michael W. Boyer, University of Utah, Salt Lake City, UT; Richard T. Maziarz, Oregon Health & Science University, Portland, OR; Paul J. Shaughnessy, Texas Transplant Institute, San Antonio; Madhuri Vusirikala, University of Texas Southwestern Medical Center, Dallas, TX; Usama Gergis, Weill Cornell Medical College; Ran Reshef, Columbia University Medical Center, New York, NY; Hana Safah, Tulane University, New Orleans, LA; John F. DiPersio and Peter Westervelt, Washington University School of Medicine, St Louis, MO; Jeff Szer, Royal Melbourne Hospital, Parkville, Victoria; Ian D. Lewis, Royal Adelaide Hospital, Adelaide, South Australia, Australia; Jennifer Holter, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Paul J. Martin, Fred Hutchinson Cancer Research Center, Seattle, WA; Joseph A. Pidala, H. Lee Moffitt Cancer Center, Tampa, FL; and Madan H. Jagasia, Vanderbilt University Medical Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.8177DOI Listing
December 2017

Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II/β-Aminopropionitrile-Induced Abdominal Aortic Aneurysm.

Hypertension 2017 11 25;70(5):959-963. Epub 2017 Sep 25.

From the Cardiovascular Research Center, Department of Physiology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA (T. Kawai, T. Takayanagi, S.J.F., K.J.P., T.O., T. Tsuji, T. Kobayashi, M.J.B., H.A.C., R.S., V.R., S.E.); Faculty of Health Sciences, Macau Special Administrative Region, University of Macau, Taipa (H.F.K.); and Department of Anesthesia and Perioperative Care, University of California, San Francisco (T.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09822DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679456PMC
November 2017

Pathological complete response in malignant pleural mesothelioma patients following induction chemotherapy: Predictive factors and outcomes.

Lung Cancer 2017 09 13;111:75-78. Epub 2017 Jul 13.

Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Asbestos Diseases Research Institute, Sydney, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.07.010DOI Listing
September 2017

PD-L1 expression predicts longer disease free survival in high risk head and neck cutaneous squamous cell carcinoma.

Pathology 2017 Aug 27;49(5):499-505. Epub 2017 Jun 27.

Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Central Clinical School, University of Sydney, Sydney, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2017.04.004DOI Listing
August 2017

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma.

J Thorac Oncol 2017 09 16;12(9):1421-1433. Epub 2017 Jun 16.

Asbestos Diseases Research Institute, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.05.024DOI Listing
September 2017

Suppression of Superfluid Density and the Pseudogap State in the Cuprates by Impurities.

Phys Rev Lett 2016 Dec 16;117(25):257003. Epub 2016 Dec 16.

Department of Physics, Clark University, Worcester, Massachusetts 01610, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevLett.117.257003DOI Listing
December 2016

Paraneoplastic cerebellar ataxia with central hypoventilation.

Neurol Neuroimmunol Neuroinflamm 2017 Jan 8;4(1):e305. Epub 2016 Dec 8.

Royal Prince Alfred Hospital, University of Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147015PMC
January 2017

Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II.

Hypertension 2017 01 28;69(1):79-86. Epub 2016 Nov 28.

From the Cardiovascular Research Center, Lewis Katz School of Medicine at Temple University, Philadelphia, PA (S.J.F., K.J.E., T.K., T.O., M.J.B., K.J.P., S.E., V.R.); and Department of Medicine, University of Virginia, Charlottesville (Z.Y.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.116.08278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145768PMC
January 2017

EGFR-Co-Mutated Advanced NSCLC and Response to EGFR Tyrosine Kinase Inhibitors.

J Thorac Oncol 2017 03 14;12(3):585-590. Epub 2016 Sep 14.

Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.09.001DOI Listing
March 2017

Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.

Pathology 2016 Oct 30;48(6):574-80. Epub 2016 Aug 30.

Sydney Medical School, The University of Sydney, Sydney, Australia; South West Clinical School, University of New South Wales, Sydney, Australia; Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2016.07.003DOI Listing
October 2016

Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer.

Epigenomics 2016 08 17;8(8):1079-85. Epub 2016 May 17.

Asbestos Diseases Research Institute, Concord, NSW 2139, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/epi-2016-0035DOI Listing
August 2016

Evolving Landscape of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

J Clin Oncol 2016 09 11;34(27):3233-4. Epub 2016 Apr 11.

Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.9952DOI Listing
September 2016

Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.

Head Neck 2016 04 24;38 Suppl 1:E1838-47. Epub 2015 Dec 24.

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.24332DOI Listing
April 2016

PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma.

Lung Cancer 2015 Aug 18;89(2):181-8. Epub 2015 May 18.

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.05.007DOI Listing
August 2015

Boric acid destabilizes the hyphal cytoskeleton and inhibits invasive growth of Candida albicans.

Yeast 2015 Apr 9;32(4):389-98. Epub 2015 Feb 9.

Department of Biochemistry and Nutrition, Des Moines University, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/yea.3066DOI Listing
April 2015

Expression and characterization of a β-fructofuranosidase from the parasitic protist Trichomonas vaginalis.

BMC Biochem 2014 Jun 28;15:12. Epub 2014 Jun 28.

Department of Biochemistry & Nutrition, Des Moines University, Des Moines, IA 50312, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2091-15-12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083873PMC
June 2014

Long-term effects of cryopreservation on clinically prepared hematopoietic progenitor cell products.

Cytotherapy 2014 Jul;16(7):965-75

University of Utah Cell Therapy and Regenerative Medicine Facility, Salt Lake City, Utah, USA; University of Utah Division of Hematology & Hematologic Malignancies, Salt Lake City, Utah, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2014.02.005DOI Listing
July 2014

Head and neck multidisciplinary team meetings: Effect on patient management.

Head Neck 2015 Jul 11;37(7):1046-50. Epub 2014 Jul 11.

Sydney Head and Neck Cancer Institute, The Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.23709DOI Listing
July 2015

Preparing for tomorrow: molecular diagnostics and the changing nonsmall cell lung cancer landscape.

Asia Pac J Clin Oncol 2014 Apr;10 Suppl 2:2-10

The Chris O'Brien Lifehouse, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12189DOI Listing
April 2014

Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures.

Cytotherapy 2013 Dec;15(12):1458-68

University of Utah Cell Therapy and Regenerative Medicine Facility, Salt Lake City, Utah, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2013.06.014DOI Listing
December 2013

Efficacy of sorafenib in advanced renal cell carcinoma independent of prior treatment, histology or prognostic group.

Asia Pac J Clin Oncol 2014 Mar 24;10(1):60-5. Epub 2013 Oct 24.

Joint Austin-Ludwig Oncology Unit, Austin Health, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12122DOI Listing
March 2014

Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.

J Clin Oncol 2013 Sep 1;31(27):3327-34. Epub 2013 Jul 1.

Lecia V. Sequist, Massachusetts General Hospital and Harvard Medical School, Boston, MA; James Chih-Hsin Yang, National Taiwan University Hospital; Chun-Ming Tsai, Taipei Veterans General Hospital, Taipei; Wu-Chou Su, National Cheng Kung University Hospital, Tainan, Taiwan; Nobuyuki Yamamoto, Shizuoka Cancer Center, Shizuoka; Terufumi Kato, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan; Kenneth O'Byrne, St James' Hospital, Dublin, Ireland; Vera Hirsh, McGill University, Montreal, Quebec, Canada; Tony Mok, Prince of Wales Hospital, Hong Kong, China; Sarayut Lucien Geater, Songklanagarind Hospital, Songkla, Thailand; Sergey Orlov, Pavlov State Medical University, St Petersburg; Vera Gorbunova, GU Russian Oncological Research Centre, Moscow, Russia; Michael Boyer, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Jaafar Bennouna, Institut de Cancérologie de l'Ouest-site René Gauducheau, Nantes, France; Ki Hyeong Lee, Chungbuk National University Hospital, Cheongju, South Korea; Riyaz Shah, Maidstone and Tunbridge Wells National Health Service Trust, Maidstone Hospital, Maidstone; Dan Massey, Victoria Zazulina, and Mehdi Shahidi, Boehringer Ingelheim, Bracknell, United Kingdom; and Martin Schuler, West German Cancer Center, University of Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.44.2806DOI Listing
September 2013

A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma.

Lung Cancer 2013 Sep 17;81(3):422-427. Epub 2013 Jun 17.

NHMRC Clinical Trials Centre, University of Sydney, Medical Foundation Building, 92-94 Parramatta Road, Camperdown, NSW 2050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.05.006DOI Listing
September 2013

Outcomes of permanent peritoneal ports for the management of recurrent malignant ascites.

J Palliat Med 2013 Aug 4;16(8):938-40. Epub 2013 Jun 4.

Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jpm.2012.0535DOI Listing
August 2013

Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma.

J Thorac Oncol 2013 Apr;8(4):408-14

Department of Medical Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318283558eDOI Listing
April 2013

Role of Hog1, Tps1 and Sod1 in boric acid tolerance of Saccharomyces cerevisiae.

Microbiology (Reading) 2012 Oct 17;158(Pt 10):2667-2678. Epub 2012 Aug 17.

Des Moines University, 3200 Grand Avenue, Des Moines, IA 50312, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1099/mic.0.060590-0DOI Listing
October 2012

Efficacy of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC): analysis of the Australian subpopulation of the TRUST study.

Asia Pac J Clin Oncol 2012 Sep 15;8(3):248-54. Epub 2012 May 15.

Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1743-7563.2012.01540.xDOI Listing
September 2012

Boric Acid Disturbs Cell Wall Synthesis in Saccharomyces cerevisiae.

Int J Microbiol 2010 27;2010:930465. Epub 2010 Dec 27.

Biochemistry and Nutrition, Des Moines University, 3200 Grand Avenue, Des Moines, IA 50312, USA.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/ijmicro/2010/930465/
Publisher Site
http://dx.doi.org/10.1155/2010/930465DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017954PMC
July 2011

What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements.

Pathology 2011 Feb;43(2):103-15

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0b013e328342629dDOI Listing
February 2011

Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.

J Natl Cancer Inst 2010 Aug 14;102(16):1253-62. Epub 2010 Jul 14.

Sydney Cancer Centre, Gloucester House 6, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW 2050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djq245DOI Listing
August 2010

The subcellular localization of yeast glycogen synthase is dependent upon glycogen content.

Can J Microbiol 2010 May;56(5):408-20

Biochemistry and Nutrition Department, Des Moines University, 3200 Grand Avenue, Des Moines, IA 50312, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1139/w10-027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888498PMC
May 2010

A pathological complete response in malignant pleural mesothelioma after combination chemotherapy with Carboplatin and pemetrexed.

J Thorac Oncol 2010 Mar;5(3):405-6

Department of Medical Oncology, Sydney Cancer Centre, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181c8cb16DOI Listing
March 2010